Latest news with #ITG
Cision Canada
4 days ago
- Business
- Cision Canada
VVT Med Inc. Engages Independent Trading Group as Market Maker
TORONTO, Aug. 13, 2025 /CNW/ - VVT Med Inc. (TSXV: VVTM) (" VVT" or the " Company"), announces that it has entered into a market making service agreement (the " Agreement") with Independent Trading Group (" ITG") dated August 13, 2025. Pursuant to the Agreement, ITG will provide market-making services in accordance with TSX Venture Exchange (the " TSVX") policies and will trade shares of the Company on the TSXV and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares. The Agreement is subject to final approval from the TSXV. ITG will receive compensation of CAD$5,000 per month, payable monthly in advance. The Agreement is for an initial term of one month and will renew for additional one-month terms unless terminated. The Agreement may be terminated by either party with 30 days' notice. There are no performance factors contained in the Agreement and ITG will not receive shares or options as compensation. ITG and the Company are unrelated and unaffiliated entities and at the time of the Agreement, neither ITG nor its principals have an interest, directly or indirectly, in the securities of the Company. About Independent Trading Group Independent Trading Group (ITG) Inc. is a Toronto based CIRO dealer-member that specializes in market making, liquidity provision, agency execution, ultra-low latency connectivity, and bespoke algorithmic trading solutions. Established in 1992, with a focus on market structure, execution and trading, ITG has leveraged its own proprietary technology to deliver high quality liquidity provision and execution services to a broad array of public issuers and institutional investors. About VVT Med Inc. VVT develops, manufactures, and commercializes minimally invasive, non-thermal, and non-tumescent solutions for the treatment of varicose veins. VVT's products offer several key competitive advantages over traditional alternatives, including faster treatment times, reduced pain without the need for anesthesia, and quicker recovery and results. Cautionary Note Regarding Forward-Looking Statements This news release contains statements that constitute "forward-looking statements". Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Forward-looking statements in this document include, among others, statements with respect to the engagement of ITG including the duration and TSXV approval of such engagement. Such statements and information reflect the current view of the Company. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. The Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.
Business Upturn
30-07-2025
- Business
- Business Upturn
Treatment.com AI Engages Market Maker
Vancouver, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — AI Inc. (the 'Company' or 'Treatment') (CSE: TRUE; OTC: TREIF; 939: FRA) has engaged the services of Independent Trading Group ('ITG') pursuant to an agreement dated and starting on July 29, 2025 (the 'Agreement') to provide market-making services in accordance with Canadian Securities Exchange ('CSE') policies. ITG will trade shares of the Company on the CSE and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares. Under the terms of the Agreement, ITG will receive compensation of CAD $5,500 per month, payable monthly in advance. The Agreement is for an initial term of one month and will renew for additional one-month terms unless terminated by either party with 30 days' notice. There is no performance factors contained in the Agreement and ITG will not receive shares or options as compensation. ITG and the Company are unrelated and unaffiliated entities. Independent Trading Group (ITG) Inc. is a Toronto based CIRO dealer-member that specializes in market making, liquidity provision, agency execution, ultra-low latency connectivity, and bespoke algorithmic trading solutions. Established in 1992, with a focus on market structure, execution and trading, ITG has leveraged its own proprietary technology to deliver high quality liquidity provision and execution services to a broad array of public issuers and institutional investors. About AI Inc. AI is a company utilizing AI and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than ~10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and enables greater consistency in quality of patient support. Treatment's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment's products and services: or email: [email protected] m FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO [email protected] For media inquiries, contact: [email protected] Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statements This news release contains forward-looking statements relating to the future operations of Treatment and other statements that are not historical facts. Forward-looking statements are often identified by terms such as 'will', 'may', 'should', 'anticipate', 'expects' and similar expressions. All statements other than statements of historical fact, included in this release, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Toronto Star
29-07-2025
- Business
- Toronto Star
Treatment.com AI Engages Market Maker
Vancouver, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — AI Inc. (the 'Company' or 'Treatment') (CSE: TRUE; OTC: TREIF; 939: FRA) has engaged the services of Independent Trading Group ('ITG') pursuant to an agreement dated and starting on July 29, 2025 (the 'Agreement') to provide market-making services in accordance with Canadian Securities Exchange ('CSE') policies. ITG will trade shares of the Company on the CSE and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares. Under the terms of the Agreement, ITG will receive compensation of CAD $5,500 per month, payable monthly in advance. The Agreement is for an initial term of one month and will renew for additional one-month terms unless terminated by either party with 30 days' notice. There is no performance factors contained in the Agreement and ITG will not receive shares or options as compensation. ITG and the Company are unrelated and unaffiliated entities.
Hamilton Spectator
29-07-2025
- Business
- Hamilton Spectator
Treatment.com AI Engages Market Maker
Vancouver, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — AI Inc. (the 'Company' or 'Treatment') (CSE: TRUE; OTC: TREIF; 939: FRA) has engaged the services of Independent Trading Group ('ITG') pursuant to an agreement dated and starting on July 29, 2025 (the 'Agreement') to provide market-making services in accordance with Canadian Securities Exchange ('CSE') policies. ITG will trade shares of the Company on the CSE and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares. Under the terms of the Agreement, ITG will receive compensation of CAD $5,500 per month, payable monthly in advance. The Agreement is for an initial term of one month and will renew for additional one-month terms unless terminated by either party with 30 days' notice. There is no performance factors contained in the Agreement and ITG will not receive shares or options as compensation. ITG and the Company are unrelated and unaffiliated entities. Independent Trading Group (ITG) Inc. is a Toronto based CIRO dealer-member that specializes in market making, liquidity provision, agency execution, ultra-low latency connectivity, and bespoke algorithmic trading solutions. Established in 1992, with a focus on market structure, execution and trading, ITG has leveraged its own proprietary technology to deliver high quality liquidity provision and execution services to a broad array of public issuers and institutional investors. About AI Inc. AI is a company utilizing AI and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than ~10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and enables greater consistency in quality of patient support. Treatment's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment's products and services: or email: info@ m FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO ehamza@ For media inquiries, contact: media@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statements This news release contains forward-looking statements relating to the future operations of Treatment and other statements that are not historical facts. Forward-looking statements are often identified by terms such as 'will', 'may', 'should', 'anticipate', 'expects' and similar expressions. All statements other than statements of historical fact, included in this release, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
Time of India
09-07-2025
- Automotive
- Time of India
Govt dashcams to log traffic offences
Panaji: The state cabinet on Wednesday granted approval for the Goa Vehicle Authentication (GoVA) System to install dashboard surveillance cameras (dashcams) on govt vehicles for recording visible traffic violations and to start automated border document verification on a public-private partnership (PPP) mode. Tired of too many ads? go ad free now The GoVA System is aimed at streamlining vehicular regulation, strengthening road safety measures, and enhancing compliance with motor vehicle and traffic laws. The system envisions a digital-first approach to document verification, resulting in greater ease of travel, particularly for tourists, and promoting the lawful use of road infrastructure. The current practice of verifying vehicle documents at state border checkposts relies predominantly on manual, random checks, which are limited in coverage and effectiveness. Numerous vehicles continue to operate without valid statutory documentation, including registration certificates, Pollution under Control (PUC) certificates, and third-party insurance, in contravention of the Central Motor Vehicles Act, 1988. This systemic gap poses significant safety concerns. The GoVA System is intended to serve as a preventive and regulatory mechanism that emphasises citizen safety and compliance, while also facilitating process efficiency and, as a secondary outcome, improving the collection of statutory revenues. To address this critical need, the home department mandated Info Tech Corporation of Goa Limited (ITG) — a govt undertaking — to initiate a technology-driven solution for real-time vehicle monitoring and verification. S Tired of too many ads? go ad free now tate govt selected Mistotex Technology Pvt Ltd as the system integrator for five years. A revenue-sharing model was proposed as follows: Goa govt - 55%, ITG - 5.5%, and system integrator - 39.5%. Under Phase I, the automated border document verification system will be put in place, and online and automated validation of vehicle documentation (including registration certificates, PUC certificates, and insurance) will occur at all designated border check-posts. Integration with the central govt's Vahan and challan databases will ensure real-time verification and centralised compliance tracking. Secure, tamper-proof QR codes will be generated to be displayed on vehicles that have cleared checks, thereby exempting them from repeat inspections. Under Phase II, a statewide vehicle monitoring and road safety system will be implemented, and dashboard surveillance cameras will be installed on official govt vehicles for recording visible traffic violations. Real-time violation capture, alert generation, and automated challan issuance will occur through backend integration. The enforcement ecosystem will be linked with modules for weighbridge monitoring, road cess collection, and route analytics. Mobile apps will be developed for enforcement officers and police to facilitate easy API integration with third-party applications such as e-Vahan, Sarthi, Digilocker, e-challan system, and any other related to the project. ITG, with the system integrator, will coordinate with Goa police for necessary technical compliance.
